PNC Financial Services Group
LBRX

PNC Financial Services Group’s LB Pharmaceuticals LBRX Stock Holding History

PNC Financial Services Group’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.96K Buy
276
+131
+90% +$3.85K ﹤0.01% 4142
2026
Q1 		$3.58K Buy
+145
New +$3.35K ﹤0.01% 4405

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PNC Financial Services Group's LBRX Position: Q2 2026 in Review

PNC Financial Services Group increased its LB Pharmaceuticals (LBRX) stake by 90% in Q2 2026, buying an estimated $3.85K and bringing the position to 276 shares worth $8.96K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

PNC Financial Services Group first reported a position in LBRX in Q1 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • PNC Financial Services Group held 276 shares of LB Pharmaceuticals worth $8.96K as of Q2 2026.
  • PNC Financial Services Group bought 131 LB Pharmaceuticals shares in Q2 2026, an estimated $3.85K.
  • LB Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4142 holding.
  • PNC Financial Services Group first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.